Phosphodiesterase type 5 inhibition may reduce diastolic function in women with ischemia but no obstructive coronary artery disease

Phosphodiesterase type 5 inhibition may reduce diastolic function in women with ischemia but no obstructive coronary artery disease

Abstract Background Ischemia, in the absence of obstructive coronary artery disease, is prevalent in women, and associated with increased risk for major cardiovascular events. Coronary microvascular dysfunction is prevalent in these patients, and associated with impaired diastolic function. Despite...

Full description

Bibliographic Details
Main Authors: Michael D. Nelson, Puja K. Mehta, Janet Wei, Behzad Sharif, Louise E. J. Thomson, Daniel Berman, Debiao Li, C. Noel Bairey Merz
Format: Article
Language:English
Published: BMC 2017-05-01
Series:Journal of Medical Case Reports
Subjects:
Women’s ischemic syndrome
Coronary microvascular dysfunction
Diastolic dysfunction
Myocardial perfusion reserve index
Phosphodiesterase type 5 inhibition
Online Access:http://link.springer.com/article/10.1186/s13256-017-1307-2

Internet

http://link.springer.com/article/10.1186/s13256-017-1307-2

Similar Items